Format
Sort by
Items per page

Send to

Choose Destination

Best matches for curcumin cancer:

Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions. Adiwidjaja J et al. Expert Opin Drug Metab Toxicol. (2017)

Liposomal curcumin and its application in cancer. Feng T et al. Int J Nanomedicine. (2017)

MicroRNA: A novel target of curcumin in cancer therapy. Mirzaei H et al. J Cell Physiol. (2018)

Search results

Items: 1 to 20 of 4908

1.

Effective Encapsulation of Curcumin in Nanoparticles Enabled by Hydrogen Bonding Using Flash Nanocomplexation.

Ke X, Tang H, Mao HQ.

Int J Pharm. 2019 Apr 19. pii: S0378-5173(19)30316-3. doi: 10.1016/j.ijpharm.2019.04.053. [Epub ahead of print]

PMID:
31009696
2.

Dual Arm Nanocapsule Targets Neuropilin-1 Receptor and Microtubule: A Potential Nanomedicine Platform.

Barman S, Das G, Gupta V, Mondal P, Jana B, Bhunia D, Khan J, Mukherjee D, Ghosh S.

Mol Pharm. 2019 Apr 22. doi: 10.1021/acs.molpharmaceut.9b00123. [Epub ahead of print]

PMID:
31009223
3.

Modulation of Biological Activities in Glioblastoma Mediated by Curcumin.

Trotta T, Panaro MA, Prifti E, Porro C.

Nutr Cancer. 2019 Apr 22:1-13. doi: 10.1080/01635581.2019.1604978. [Epub ahead of print]

PMID:
31007066
4.

Curcumin induces apoptotic cell death and protective autophagy by inhibiting AKT/mTOR/p70S6K pathway in human ovarian cancer cells.

Liu LD, Pang YX, Zhao XR, Li R, Jin CJ, Xue J, Dong RY, Liu PS.

Arch Gynecol Obstet. 2019 Apr 21. doi: 10.1007/s00404-019-05058-3. [Epub ahead of print]

PMID:
31006841
5.

Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.

Hu C, Li M, Guo T, Wang S, Huang W, Yang K, Liao Z, Wang J, Zhang F, Wang H.

Phytomedicine. 2018 Nov 12;58:152740. doi: 10.1016/j.phymed.2018.11.001. [Epub ahead of print]

PMID:
31005718
6.

Curcumin and Intestinal Inflammatory Diseases: Molecular Mechanisms of Protection.

Burge K, Gunasekaran A, Eckert J, Chaaban H.

Int J Mol Sci. 2019 Apr 18;20(8). pii: E1912. doi: 10.3390/ijms20081912. Review.

7.

Over-expression of DJ-1 attenuates effects of curcumin on colorectal cancer cell proliferation and apoptosis.

Shang H, Wang T, Shang F, Li M, Luo Y, Huang KM.

Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):3080-3087. doi: 10.26355/eurrev_201904_17591.

PMID:
31002157
8.

Monocarbonyl curcumin analog A2 potently inhibits angiogenesis by inducing ROS-dependent endothelial cell death.

Liu B, Cui LS, Zhou B, Zhang LL, Liu ZH, Zhang L.

Acta Pharmacol Sin. 2019 Apr 18. doi: 10.1038/s41401-019-0224-x. [Epub ahead of print]

PMID:
31000770
9.

Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer.

Khan S, Setua S, Kumari S, Dan N, Massey A, Hafeez BB, Yallapu MM, Stiles ZE, Alabkaa A, Yue J, Ganju A, Behrman S, Jaggi M, Chauhan SC.

Biomaterials. 2019 Apr 8;208:83-97. doi: 10.1016/j.biomaterials.2019.04.005. [Epub ahead of print]

PMID:
30999154
10.

Determination and pharmacokinetic study of isothiouronium-modified pyrimidine-substituted curcumin analog (1G), a novel antitumor agent, in rat plasma by liquid chromatography-tandem mass spectrometry.

Sun J, Wang J, Ma L, Jiang T, Li X, Guo Q, Li X, Sui Z.

Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1505-1512. doi: 10.1080/21691401.2019.1602537.

PMID:
30991858
11.

A novel curcumin derivative CL-6 exerts antitumor effect in human gastric cancer cells by inducing apoptosis through Hippo-YAP signaling pathway.

Ye C, Wang W, Xia G, Yu C, Yi Y, Hua C, Tu F, Shen L, Chen C, Sun W, Zheng Z.

Onco Targets Ther. 2019 Mar 27;12:2259-2269. doi: 10.2147/OTT.S196914. eCollection 2019.

12.

Ultrasound Triggered Spatiotemporal Delivery of Topotecan and Curcumin as Combination Therapy for Cancer.

Prasad C, Banerjee R.

J Pharmacol Exp Ther. 2019 Apr 15. pii: jpet.119.256487. doi: 10.1124/jpet.119.256487. [Epub ahead of print]

13.
14.

Apoptosis induced by luteolin in breast cancer: Mechanistic and therapeutic perspectives.

Ahmed S, Khan H, Fratantonio D, Hasan MM, Sharifi S, Fathi N, Ullah H, Rastrelli L.

Phytomedicine. 2019 Mar 10;59:152883. doi: 10.1016/j.phymed.2019.152883. [Epub ahead of print] Review.

PMID:
30986716
15.

The Antitumor Effect of Curcumin in Urothelial Cancer Cells Is Enhanced by Light Exposure In Vitro.

Roos F, Binder K, Rutz J, Maxeiner S, Bernd A, Kippenberger S, Zöller N, Chun FK, Juengel E, Blaheta RA.

Evid Based Complement Alternat Med. 2019 Mar 11;2019:6374940. doi: 10.1155/2019/6374940. eCollection 2019.

16.

Autophagy as a molecular target for cancer treatment.

Kocaturk NM, Akkoc Y, Kig C, Bayraktar O, Gozuacik D, Kutlu O.

Eur J Pharm Sci. 2019 Apr 11. pii: S0928-0987(19)30149-6. doi: 10.1016/j.ejps.2019.04.011. [Epub ahead of print]

PMID:
30981885
17.

Drug induced micellization into ultra-high capacity and stable curcumin nanoformulations: Physico-chemical characterization and in vitro evaluation in 2D/3D in vitro models.

Lübtow MM, Nelke LC, Seifert J, Kühnemundt J, Sahay G, Dandekar G, Nietzer S, Luxenhofer R.

J Control Release. 2019 Apr 11. pii: S0168-3659(19)30214-7. doi: 10.1016/j.jconrel.2019.04.014. [Epub ahead of print]

PMID:
30981815
18.

Curcumin: a potent agent to reverse epithelial-to-mesenchymal transition.

Bahrami A, Majeed M, Sahebkar A.

Cell Oncol (Dordr). 2019 Apr 13. doi: 10.1007/s13402-019-00442-2. [Epub ahead of print] Review.

PMID:
30980365
19.

Advances in phytochemical delivery systems for improved anticancer activity.

Lagoa R, Silva J, Rodrigues JR, Bishayee A.

Biotechnol Adv. 2019 Apr 9. pii: S0734-9750(19)30063-1. doi: 10.1016/j.biotechadv.2019.04.004. [Epub ahead of print] Review.

PMID:
30978386
20.

Curcumin: Total-Scale Analysis of the Scientific Literature.

Yeung AWK, Horbańczuk M, Tzvetkov NT, Mocan A, Carradori S, Maggi F, Marchewka J, Sut S, Dall'Acqua S, Gan RY, Tancheva LP, Polgar T, Berindan-Neagoe I, Pirgozliev V, Šmejkal K, Atanasov AG.

Molecules. 2019 Apr 9;24(7). pii: E1393. doi: 10.3390/molecules24071393.

Supplemental Content

Loading ...
Support Center